The assessment of the treatment results in cervical adenocarcinoma patients
Affiliation and adress for correspondence

Klinika Nowotworów Narządów Płciowych Kobiecych, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie w Warszawie.
Kierownik Kliniki: doc. dr hab. n. med. Mariusz Bidziński
Correspondence to: Klinika Nowotworów Narządów Płciowych Kobiecych, Centrum Onkologii – Instytut im. Marii Skłodowskiej-Curie, ul. Roentgena 5, 02-781 Warszawa
Source of financing: Department own sources

GIN ONKOL, 2005, 3 (3), p. 146-152

The aim of this paper was the assessment of the overall survival in cervical adenocarcinoma patients and its comparison to the data in the literature. The clinical material constituted the group of 142 cervical adenocarcinoma patients, treated between January 1989 and December 1999 at Gynecological Oncology Department of Maria Sklodowska-Curie Memorial Cancer Center – Institute in Warsaw. The analyzed patients were treated with the following methods: surgery with adjuvant radiotherapy, or radiotherapy alone. The analysis of the overall survival in dependence on the selected clinical and population’s factors was performed. The above data were analyzed, using the Kaplan-Meier’s method and Cox’s proportional hazards model. The level of statistical significance was p=0.05. Results: The follow-up median time for surviving patients (N=65) was 81 months (40.5 to 174). The 5-year survival for the whole group was 45%. The 5-year survival for each clinical stage, according to FIGO, was as follows: IB – 63%, II – 48%, III – 18%. Conclusions: In the analyzed material, the 5-year survival rate in cervical adenocarcinoma was lower, when compared to the data in the literature, but similar to the data containing results about the 5-year survival in cervical adenocarcinoma in Poland.

Keywords: adenocarcinoma, uterine cervix, treatment results, radiotherapy, brachytherapy, surgery, literature data